NCT04234165

Brief Summary

Study design: This was a single center, parallel arm, randomized, controlled trial done at Tribhuvan University Teaching Hospital,Institute Of Medicine from May 2017 to April 2018. The allocation ratio was 1:1. Inclusion criteria: All patients undergoing Transurethral Resection of Bladder Tumor for suspected bladder tumors. Exclusion criteria were: Consent withdrawal, bladder tumour other than in the lateral wall, unfit for spinal anesthesia and need of general anesthesia or obturator nerve block. Methodology: All patients suspected to have bladder cancer were subjected to imaging or cystoscopy and with confirmation of the diagnosis; they were randomized into two arms of TURBT. Spinal anesthesia was used in all cases. To overcome the potential confounding effect on our primary end point, obturator jerk, nerve block was not used. Cystoscopy was done first and the findings were noted before proceeding to TURBT. Tumors were resected in block from periphery to center with the stalk resected last. An additional sample of deep muscle was obtained from the tumor base and sent for histopathological examination in different containers. All study variables were recorded in Per forma during the operation and in post operative period. Hemoglobin and sodium level was determined in immediate post operative period. Postoperative irrigation was done with normal saline in both the resection groups and continued till the urine was clear. The catheter was removed after 48 hours in uncomplicated cases and patients were discharged. Patients were followed up in OPD at 2 weeks with the

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
70

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2017

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2017

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2018

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2018

Completed
1.2 years until next milestone

First Submitted

Initial submission to the registry

January 9, 2020

Completed
12 days until next milestone

First Posted

Study publicly available on registry

January 21, 2020

Completed
Last Updated

January 21, 2020

Status Verified

January 1, 2020

Enrollment Period

11 months

First QC Date

January 9, 2020

Last Update Submit

January 15, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • obturator jerk occurrence

    occurrence of obturator jerk (yes/no) will be recorded

    during TURBT

Secondary Outcomes (9)

  • bladder perforation(yes/no)

    during TURBT

  • time of resection (minutes

    during TURBT

  • TUR syndrome (yes/no)

    during and after operation

  • decrease in hemoglobin (mg/dl)

    immediate post operative period

  • serum sodium(meq/l)

    immediate post operative period

  • +4 more secondary outcomes

Study Arms (2)

Monopolar arm

ACTIVE COMPARATOR

monopolar cautery was used for TURBT

Device: TURBT

Bipolar Arm

EXPERIMENTAL

bipolar cautery was used for TURBT

Device: TURBT

Interventions

TURBTDEVICE

different power sources ( bipolar vs monopolar)

Bipolar ArmMonopolar arm

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • All patients undergoing TURBT for suspected bladder tumors.

You may not qualify if:

  • Consent withdrawal, bladder tumour other than in the lateral wall, unfit for spinal anesthesia and need of general anesthesia or obturator nerve block.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

TUTH

Kathmandu, Three, 44600, Nepal

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Urology Lectuerer

Study Record Dates

First Submitted

January 9, 2020

First Posted

January 21, 2020

Study Start

May 1, 2017

Primary Completion

April 1, 2018

Study Completion

November 1, 2018

Last Updated

January 21, 2020

Record last verified: 2020-01

Data Sharing

IPD Sharing
Will share

online availability

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE

Locations